Health Optimization Index
Vitamin C (Ascorbic Acid)
- Nick’s assessment
- Favorable
- Research evidence
- B, good evidence
- Attention
- 22.7 / 100▲ Rising this week
BioHarmony score
Vitamin C is an essential water-soluble nutrient that decisively corrects deficiency (scurvy) and shows modest, real benefits beyond it: a 3.84 mmHg systolic blood pressure drop per the Juraschek 2012 meta-analysis and an 8 percent shorter cold in adults per the Hemila 2013 Cochrane review. It scores 7.5–8.0/10 on the BioHarmony scale.
Read the full report Benefits, risks and practical guidance.
In the news this week: Dr. Stillman.
Read Nick’s assessment Why it earned this rating
Vitamin C scores 7.5–8.0/10 because the floor is so high and the downside so small: it is essential, decisively effective for deficiency, very safe, and nearly free, with modest real bonuses for blood pressure, glycemia, iron absorption, and cold duration. The practical verdict is to treat it as a cheap nutritional insurance policy rather than a hero supplement. It belongs in the Strong recommend tier not because it transforms healthy people, but because ensuring adequacy is genuinely valuable and the risk of doing so is almost nil. The people who should skip megadoses are healthy, well-fed adults chasing grams or IV drips for benefits the evidence does not support.
✅ Best for: People with low dietary fruit and vegetable intake, who are the clearest beneficiaries of correction. Smokers and heavy drinkers, who have measurably higher requirements. Athletes and others under heavy physical stress, where Hemila 2013 showed regular vitamin C halved cold incidence. Hypertensive adults wanting a cheap adjunct for the modest blood pressure effect from Juraschek 2012. People with type 2 diabetes, where the glycemic signal concentrates at higher doses. Vegetarians and the iron-deficient, who benefit from co-taking it with plant-based iron. The elderly, malnourished, and post-surgical, where adequate vitamin C supports wound healing.
❌ Avoid if: You have a kidney-stone history, chronic kidney disease, or oxalate-stone tendency, since supplemental doses at or above 1000 mg/day roughly doubled stone risk in men. You have hemochromatosis or another iron-overload condition, because vitamin C increases iron absorption. You have G6PD deficiency, where very high doses can trigger hemolysis. You expect grams to deliver dramatic benefits in an already-replete body, or you are considering intravenous vitamin C for cancer or sepsis on the strength of marketing, since the Fowler 2019 sepsis trial and the cancer evidence do not support those frames.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →